Omnia SanaPlant Comparison
Astragalus vs Elecampane
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Astragalus and Elecampane: they share 5 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Astragalus | Elecampane | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Cancer (anticancer research) | 2/10 | 2/10 | Comparable evidence |
| Infection (general) | 2/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Major bioactive saponin with cardio-, neuro-, hepato- and renoprotective effects.
The antimicrobial and anti-inflammatory principles of the root; the eudesmane core and the alpha,beta-methylene-lactone ring are essential for the antimicrobial activity.
A fructan polysaccharide abundant in the root (the genus Inula gives inulin its name).
Pharmacological Actions
Astragalus membranaceus and its constituents (astragaloside IV, cycloastragenol, Astragalus polysaccharide) inhibit tumour growth, invasion and metastasis and enhance antitumour immunity across lung, colorectal and gastrointestinal cancers (preclinical, incl. in vivo).
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes)
Anti-inflammatory - sesquiterpene lactones (alantolactone, isoalantolactone) inhibit NF-kB and MAPK signalling and pro-inflammatory cytokines; total sesquiterpene lactones eased arthritis in animal models (potential in rheumatoid arthritis)
Antimicrobial, notably anti-staphylococcal (membrane-damaging) and anti-mycobacterial (active against Mycobacterium tuberculosis in vitro); supports respiratory and skin infection
Traditional & Indicated Uses
inferred from anti-inflammatory action
Astragalus membranaceus protects against gastrointestinal cancers; astragaloside IV inhibits lung cancer metastasis via macrophage repolarization, cycloastragenol boosts CD8+ T-cell antitumour immunity (with anti-PD-1 synergy), and Astragalus polysaccharide suppresses inflammation-induced colorectal cancer (preclinical).
Supports resistance to colds and respiratory infection (immune)
Adaptogenic tonic for fatigue and low vitality (traditional 'Qi' tonic)
Immune support / immunomodulation (activates macrophages, NK cells, T and B lymphocytes); Supports resistance to colds and respiratory infection (immune)
Supports resistance to colds and respiratory infection (immune)
inferred from anti-inflammatory action
Renoprotective (kidney support) - as an adjunct in chronic kidney disease, reduced proteinuria and raised haemoglobin and serum albumin across trials (Cochrane review; study quality low)
inferred from anti-inflammatory action
Anti-inflammatory - sesquiterpene lactones (alantolactone, isoalantolactone) inhibit NF-kB and MAPK signalling and pro-inflammatory cytokines; total sesquiterpene lactones eased arthritis in animal models (potential in rheumatoid arthritis)
Expectorant for productive cough and bronchitis (long-standing respiratory remedy)
inferred from anticancer action
Expectorant for productive cough and bronchitis (long-standing respiratory remedy); Soothes irritated airways / chronic catarrh (traditional)
Antimicrobial, notably anti-staphylococcal (membrane-damaging) and anti-mycobacterial (active against Mycobacterium tuberculosis in vitro); supports respiratory and skin infection
inferred from anti-inflammatory action
inferred from expectorant action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Astragalus stimulates immune activity; on theoretical grounds it should be used cautiously in autoimmune disease and with immunosuppressant medicines (for example after organ transplant) - discuss with a clinician.
Generally well tolerated; high-quality long-term human safety and toxicity data remain limited.
Safety in pregnancy and breastfeeding has not been established; avoid medicinal doses.
The sesquiterpene lactones (especially alantolactone) are known skin sensitisers and can cause allergic contact dermatitis; people sensitive to the daisy family (Asteraceae) should be cautious.
Large doses can cause nausea, vomiting and diarrhoea; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
External Ids
Botanical Description
Erect perennial herb with a long, fibrous, pale yellow taproot. The leaves are pinnately compound with numerous small, oval leaflets, giving a soft, ferny appearance. Small, pale yellow, pea-like flowers are borne in loose axillary clusters (racemes), followed by membranous, inflated seed pods that give the species its name.[5]
Tall, robust perennial herb with large, coarse, hairy leaves - broadly oval near the base and progressively smaller up the stem - arising from a thick, aromatic rhizome. Large, shaggy, bright yellow daisy-like flower heads with numerous narrow ray florets are borne at the top of stout, branching stems.[12]
Habitat
Native to the grasslands, sunny slopes and forest margins of northern and north-eastern China, Mongolia and parts of Korea; widely cultivated as a medicinal crop across East Asia.[5]
Grows in damp meadows, pastures, roadsides and woodland margins on moist, rich soils; native to Europe and Western Asia and naturalised in North America.[12]
Harvesting
The root is dug from plants at least four years old, typically in spring or autumn, then cleaned and dried, often sliced into the characteristic pale, fibrous 'coin' slices used in traditional decoctions.[5]
The root and rhizome are dug in autumn of the second or later year, when sesquiterpene lactone and inulin content is highest, then cleaned, sliced and dried.[12]
Traditional Uses
Elecampane root has a long European tradition, reflected in the old name 'elf dock', as a warming expectorant remedy for productive cough, bronchitis and chronic respiratory catarrh, and topically and internally as an antimicrobial for skin and wound infections.[12]
Preparations
Dried root simmered in water as a traditional expectorant and antimicrobial tea.
Dosage
The WHO monograph on Radix Astragali gives doses of 3-9 g per day. Traditional Chinese medicine references often cite a considerably higher 9-30 g of dried root per day; WHO's figure is the conservative regulatory-tier one and is stated here in preference. Educational reference only, not a prescription.
Clinical studies commonly use extracts providing the equivalent of several grams of dried root daily, in divided doses. Educational reference only, not a prescription.
Not documented
References
Lookalikes Review
References & Sources
- Xu, B., Huang, J.P., Peng, G., Cao, W., Liu, Z. et al (2024) 'Total biosynthesis of the medicinal triterpenoid saponin astragalosides', Nature Plants, 10(11), pp. 1826-1837. doi:10.1038/s41477-024-01827-4 Preclinical
https://doi.org/10.1038/s41477-024-01827-4 - Auyeung, K.K., Han, Q.B. and Ko, J.K (2016) 'Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers', The American Journal of Chinese Medicine, 44(1), pp. 1-22. doi:10.1142/S0192415X16500014 Traditional / reference
https://doi.org/10.1142/S0192415X16500014 - Zhang, Y., Ji, W., Qin, H., Chen, Z., Zhou, Y. et al (2024) 'Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner', Carbohydrate Polymers, 349, pp. 122829. doi:10.1016/j.carbpol.2024.122829 Preclinical
https://doi.org/10.1016/j.carbpol.2024.122829 - Fu, J., Wang, Z., Huang, L., Zheng, S., Wang, D., Chen, S., Zhang, H. and Yang, S (2014) 'Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)', Phytotherapy Research, 28(9), pp. 1275-1283. doi:10.1002/ptr.5188 Meta-analysis / review
https://doi.org/10.1002/ptr.5188 - Zhang, J., Wu, C., Gao, L., Du, G. and Qin, X (2019) 'Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects', Advances in Pharmacology. doi:10.1016/bs.apha.2019.08.002 Traditional / reference
https://doi.org/10.1016/bs.apha.2019.08.002 - Dong, M., Li, J., Yang, D., Li, M. and Wei, J (2023) 'Biosynthesis and pharmacological activities of flavonoids, triterpene saponins and polysaccharides derived from Astragalus membranaceus', Molecules, 28(13), pp. 5018. doi:10.3390/molecules28135018 Meta-analysis / review
https://doi.org/10.3390/molecules28135018 - Chen, G., Jiang, N., Zheng, J., Hu, H., Yang, H., Lin, A., Hu, B. and Liu, H (2023) 'Structural characterization and anti-inflammatory activity of polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 241, pp. 124386. doi:10.1016/j.ijbiomac.2023.124386 Preclinical
https://doi.org/10.1016/j.ijbiomac.2023.124386 - Zheng, Q., Zhuang, Z., Wang, Z., Deng, L., Jin, W., Huang, Z., Zheng, G. and Wang, Y (2020) 'Clinical and preclinical systematic review of Astragalus membranaceus for viral myocarditis', Oxidative Medicine and Cellular Longevity, 2020, pp. 1560353. doi:10.1155/2020/1560353 Meta-analysis / review
https://doi.org/10.1155/2020/1560353 - Dai, Y., Wang, Y., Kang, Q., Wu, Y., Liu, Y., Su, Y., Wang, X., Xiu, M. and He, J (2024) 'The protective effect and bioactive compounds of Astragalus membranaceus against neurodegenerative disorders via alleviating oxidative stress in Drosophila', FASEB Journal, 38(13), pp. e23727. doi:10.1096/fj.202400390R Preclinical
https://doi.org/10.1096/fj.202400390R - Xu, L., Xu, X., Hou, X., Wang, F., Gao, S. and Zhang, H (2019) 'Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review', Metabolic Brain Disease, 35(1), pp. 83-93. doi:10.1007/s11011-019-00483-4 Meta-analysis / review
https://doi.org/10.1007/s11011-019-00483-4 - Li, C.X., Liu, Y., Zhang, Y.Z., Li, J.C. and Lai, J (2022) 'Astragalus polysaccharide: a review of its immunomodulatory effect', Archives of Pharmacal Research. doi:10.1007/s12272-022-01393-3 Preclinical
https://doi.org/10.1007/s12272-022-01393-3 - Jin, M., Zhao, K., Huang, Q. and Shang, P (2014) 'Structural features and biological activities of the polysaccharides from Astragalus membranaceus', International Journal of Biological Macromolecules, 64, pp. 257-266. doi:10.1016/j.ijbiomac.2013.12.002 Preclinical
https://doi.org/10.1016/j.ijbiomac.2013.12.002 - Liu, Y. and Lv, W (2019) 'Research progress in Astragalus membranaceus and its active components on immune responses in liver fibrosis', Chinese Journal of Integrative Medicine, 26(10), pp. 794-800. doi:10.1007/s11655-019-3039-1 Meta-analysis / review
https://doi.org/10.1007/s11655-019-3039-1 - World Health Organization (1999) 'Radix Astragali'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - Xu, F. and Cui, W.-Q. and Wei, Y. and Cui, J. and Qiu, J. and Hu, L.-L. and Gong, W.-Y. and Dong, J.-C. and Liu, B.-J (2018) 'Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling', Journal of Experimental & Clinical Cancer Research, 37(1), pp. 207. doi:10.1186/s13046-018-0878-0 Preclinical
https://doi.org/10.1186/s13046-018-0878-0 - Deng, G. and Zhou, L. and Wang, B. and Sun, X. and Zhang, Q. and Chen, H. and Wan, N. and Ye, H. and Wu, X. and Sun, D. and Sun, Y. and Cheng, H (2022) 'Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation', Journal for ImmunoTherapy of Cancer, 10(10), pp. e004874. doi:10.1136/jitc-2022-004874 Preclinical
https://doi.org/10.1136/jitc-2022-004874 - Li, Q. and Zhang, C. and Xu, G. and Shang, X. and Nan, X. and Li, Y. and Liu, J. and Hong, Y. and Wang, Q. and Peng, G (2024) 'Astragalus polysaccharide ameliorates CD8 T cell dysfunction through STAT3/Gal-3/LAG3 pathway in inflammation-induced colorectal cancer', Biomedicine & Pharmacotherapy, 171, pp. 116172. doi:10.1016/j.biopha.2024.116172 Preclinical
https://doi.org/10.1016/j.biopha.2024.116172 - Zhang, H.W., Lin, Z.X., Xu, C., Leung, C. and Chan, L.S (2014) 'Astragalus (a traditional Chinese medicine) for treating chronic kidney disease', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD008369.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD008369.pub2
- Gierlikowska, B., Gierlikowski, W., Bekier, K., Skalicka-Wozniak, K., Czerwinska, M.E. and Kiss, A.K (2019) 'Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium', Journal of Ethnopharmacology, 249, pp. 112311. doi:10.1016/j.jep.2019.112311 Preclinical
https://doi.org/10.1016/j.jep.2019.112311 - Gao, S. and Wang, Q. and Tian, X.H. and Li, H.L. and Shen, Y.H. and Xu, X.K. and Wu, G.Z. and Hu, Z.L. and Zhang, W.D (2016) 'Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis', Journal of Ethnopharmacology, pp. 39--46. doi:10.1016/j.jep.2016.12.020 Preclinical
https://doi.org/10.1016/j.jep.2016.12.020 - Wang, Q., Gao, S., Wu, G., Yang, N., Zu, X., Li, W., Xie, N., Zhang, R., Li, C., Hu, Z. and Zhang, W (2018) 'Total sesquiterpene lactones isolated from Inula helenium L. attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice', Phytomedicine, 46, pp. 78-84. doi:10.1016/j.phymed.2018.04.036 Preclinical
https://doi.org/10.1016/j.phymed.2018.04.036 - Dao, T.T.P., Song, K., Kim, J.Y. and Kim, Y.S (2020) 'Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling', Inflammation Research, 69(3), pp. 309-319. doi:10.1007/s00011-020-01322-4 Preclinical
https://doi.org/10.1007/s00011-020-01322-4 - He, X., Zhao, W., Shao, B., Zhang, B., Liu, T., Sun, C., Huang, H., Wu, J., Liang, J. and Ma, X (2020) 'Natural soluble epoxide hydrolase inhibitors from Inula helenium and their interactions with soluble epoxide hydrolase', International Journal of Biological Macromolecules, 161, pp. 1465-1474. doi:10.1016/j.ijbiomac.2020.04.227 Preclinical
https://doi.org/10.1016/j.ijbiomac.2020.04.227 - Buza, V., Niculae, M., Hanganu, D., Pall, E., Burtescu, R.F., Olah, N., Matei-Latiu, M., Vlasiuc, I., Iozon, I., Szakacs, A.R., Ielciu, I. and Stefanut, L.C (2022) 'Biological Activities and Chemical Profile of Gentiana asclepiadea and Inula helenium Ethanolic Extracts', Molecules, 27(11), pp. 3560. doi:10.3390/molecules27113560 Preclinical
https://doi.org/10.3390/molecules27113560 - Zheng, X., Wu, Z., Xu, J., Zhang, X., Tu, Y., Lei, J., Yuan, R., Cheng, H., Wang, Q. and Yu, J (2021) 'Bioactive sesquiterpenes from Inula helenium', Bioorganic Chemistry, 114, pp. 105066. doi:10.1016/j.bioorg.2021.105066 Preclinical
https://doi.org/10.1016/j.bioorg.2021.105066 - Nder, A.E (2021) 'Efficacy of methanol-water extract of Inula helenium root against oxidative DNA damage', Journal of Traditional Chinese Medicine, 41(2), pp. 293-300. Preclinical
https://scholar.google.com/scholar?q=Efficacy%20of%20methanol-water%20extract%20of%20Inula%20helenium%20root%20against%20oxidative%20DNA%20damage - Chun, J., Song, K. and Kim, Y.S (2018) 'Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells', Phytotherapy Research, 32(12), pp. 2501-2509. doi:10.1002/ptr.6189 Preclinical
https://doi.org/10.1002/ptr.6189 - Li, Y., Ni, Z., Zhu, M., Dong, M., Wang, S., Shi, Q., Zhang, M., Wang, Y., Huo, C., Kiyota, H. and Cong, B (2012) 'Antitumour activities of sesquiterpene lactones from Inula helenium and Inula japonica', Zeitschrift fur Naturforschung C, 67(7-8), pp. 375-380. doi:10.1515/znc-2012-7-804 Preclinical
https://doi.org/10.1515/znc-2012-7-804 - Yan, Y.Y., Zhang, Q., Zhang, B., Yang, B. and Lin, N.M (2019) 'Active ingredients of Inula helenium L. exhibits similar anti-cancer effects as isoalantolactone in pancreatic cancer cells', Natural Product Research, 34(17), pp. 2539-2544. doi:10.1080/14786419.2018.1543676 Preclinical
https://doi.org/10.1080/14786419.2018.1543676 - Kenny, C.R., Stojakowska, A., Furey, A. and Lucey, B (2022) 'From Monographs to Chromatograms: The Antimicrobial Potential of Inula helenium L. (Elecampane) Naturalised in Ireland', Molecules. doi:10.3390/molecules27041406 Traditional / reference
https://doi.org/10.3390/molecules27041406 - Stojanovic-Radic, Z. and Comic, Lj. and Radulovic, N. and Blagojevic, P. and Denic, M. and Miltojevic, A. and Rajkovic, J. and Mihajilov-Krstev, T (2012) 'Antistaphylococcal activity of Inula helenium L. root essential oil: eudesmane sesquiterpene lactones induce cell membrane damage', European Journal of Clinical Microbiology & Infectious Diseases, 31(6), pp. 1015--1025. doi:10.1007/s10096-011-1400-1 Preclinical
https://doi.org/10.1007/s10096-011-1400-1 - Cantrell, C.L. and Abate, L. and Fronczek, F.R. and Franzblau, S.G. and Quijano, L. and Fischer, N.H (1999) 'Antimycobacterial eudesmanolides from Inula helenium and Rudbeckia subtomentosa', Planta Medica, 65(4), pp. 351--355. doi:10.1055/s-1999-14001 Preclinical
https://doi.org/10.1055/s-1999-14001
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.